| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Moderate Risk of CVD | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cardiovascular Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Placebo | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Aspirin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antirheumatic Agents | |||||
| Cardiovascular Agents | |||||
| Central Nervous System Agents | |||||
| Cyclooxygenase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Fibrin Modulating Agents | |||||
| Fibrinolytic Agents | |||||
| Hematologic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Bayer | |||||
|
